The BIA’s Cell and Gene Therapy Advisory Committee (CGTAC) represents the majority of the UK’s regenerative medicine industry with over 30 UK companies (SMEs and big pharma) and key organisations including the Cell and Gene Therapy Catapult, and the Knowledge Transfer Network (KTN) and Innovate UK.

2019 priorities


Promote UK excellence in cell and gene therapies both internationally and with UK policy-makers:

Via partnerships with the Alliance for Regenerative Medicine and Phacilitate

Using the BIA’s Cell and Gene Therapy Explained document


Inform BIA policy work on:

Industrial Strategy and implementation of the Life Sciences Sector Deal, keeping Cell and Gene Therapy central to Industrial Strategy, especially in relation to innovation policy and support

NHS access and reimbursement for cell and gene therapies including responding to potential opportunities presented by the Accelerated Access Collaborative and keeping abreast of the Advanced Therapy Treatment Centres

Use of NHS patient data


Expert advice

Input to the development of measurements and standards for cell and gene therapies via the MHRA, (including NIBSC), the National Measurement System (including  LGC), the British Standards Institute, the Standards Coordinating Body and FIRM

Respond to increasing government interest in cell and gene therapies and feed in to government-led activity as appropriate.

Committee Chair: Dr Sven Kili, former VP and Head of Gene Therapy Development, GSK

For more information contact Peter Wasson, Policy and Public Affairs Manager

Member list

Advanced Centre for Biochemical Engineering, University College London

The Advanced Centre for Biochemical Engineeering hosts the MBI® Modular Training Programme for the Bioindustries.

Asymptote Ltd

Asymptote specialises in cryopreservation and liquid nitrogen-free freezers developed for GMP compliant cold chains for regenerative medicine and biobanking.


Autolus is biotechnology company focussed on the development and commercialisation of engineered T-cell therapies for haematological and solid tumours.

Azellon Ltd

Azellon is a spin-out company from The University of Bristol focused on the development and commercialisation of a platform technology using mesenchymal stem cells infused into a biological scaffold for tissue repair - the Cell Bandage.

Biodivide Ltd

Biodivide has the vision to transform the regenerative medicine field by addressing challenges in the complete workflow from stem cell harvest, manufacture, cryostorage to clinical administration.

BioMarin Europe Ltd

BioMarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes

Boult Wade Tennant

Intellectual Property Law firm with expertise in Biotechnology and Life Sciences, Chemical and Materials, Engineering and Designs, High Tech and Electrical and, Trade Mark and Domain Names.

Bristows LLP

Bristows is a dynamic and globally recognised law firm based in London with a client base that comes from a wide range of industries and includes some of the world’s leading companies.

Cell and Gene Therapy Catapult

The Cell and Gene Therapy Catapult was established in 2012 as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation.

Cell Medica Ltd

Cell Medica is a clinical cellular therapeutics company engaged in the development, manufacture and marketing of cellular immunotherapy treatments for infectious disease and cancer.

Cellular Therapeutics Ltd

Cellular Therapeutics is focused on “Personalised cellular medicine” using the patient’s own immune system to be harnessed in order to fight disease.

Cobra Biologics

Cobra provides a comprehensive biopharmaceuticals service offering, with multi-functional project teams nurturing products from pre-clinical to commercial scale GMP manufacture.

eXmoor Pharma Concepts Ltd

eXmoor pharma is a technical and strategic consultancy in biopharmaceuticals, secondary pharmaceuticals and cell & gene therapies. We work in capital projects and GMP biomanufacturing.


Field Fisher Waterhouse is a European law firm providing commercial solutions across a range of industry sectors. We have a particular focus on companies that are highly regulated and those with intellectual property and technology driven business models.

GE Healthcare UK Ltd

GE is a global infrastructure, finance and media company taking on the world's toughest challenges.

Gilead Sciences Ltd


Horizon Discovery

Horizon is a revenue-generating life science group supplying research tools to organizations engaged in translational genomics research and the development of personalized medicines.

Innovate UK


LGC is an international science-based company and market leader in analytical, forensic, biotechnology, diagnostic and product services and reference standards.


LifeArc is the new name for MRC Technology, a medical research charity with a 25 year legacy of helping scientists and organisations turn their research into treatments and diagnostics for patients.

LIfT Biosciences

LIfT Biosciences is bringing a first-in-class innate immuno-oncology therapy to market. The first cell therapy to work in solid tumours.

Lonza Biologics plc

As a worldwide leader supplying the pharmaceutical and biotechnology industries with biopharmaceuticals, Lonza furnishes seven different markets with state-of-the-art products, services, and research.

Miltenyi Biotec Ltd

Moorfields Eye Hospital Biomedical Research Centre

Moorfields Pharmaceuticals is the manufacturing arm of Moorfields Eye Hospital NHS Foundation Trust. We produce nearly 100 ophthalmic specials and have a growing portfolio of branded licensed products.

NHS Blood and Transplant

The Clinical Translation Partnerships (CTP) was established in 2010 to support scientists bringing new cellular therapies into clinical practice.

Orchard Therapeutics

Oxford BioMedica plc

Oxford BioMedica plc (LSE: OXB) is a biopharmaceutical company developing innovative gene-based medicines and therapeutic vaccines that aim to improve the lives of patients with high unmet medical needs.

Pall Life Sciences

Pall Corporation (NYSE:PLL) is a global leader in the high-tech filtration, separation and purification industry. We’ve become an industry leader by helping a diverse range of customers solve complex fluid management challenges.


Expert global consultancy specialising in access for orphan drugs.

ReNeuron Group Plc

ReNeuron are a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.

Roslin Cell Therapies

Roslin Cells are world leaders in the isolation of new clinical grade pluripotent stem cells for use in research and therapy.

Sarepta Therapeutics

Sarepta Therapeutics is a commercial stage biopharmaceutical company developing RNA targeted and Gene therapies for rare neuromuscular diseases.

TAP Biosystems

TAP Biosystems (TAP) is an innovative UK company providing automation systems and services to improve productivity in life science research, development and production.

Thermo Fisher Scientific